These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6693133)

  • 1. Study on C3-like factor in the serum of a C3-deficient subject.
    Kitamura H; Nishimukai H; Sano Y; Nagaki K
    Immunology; 1984 Feb; 51(2):239-45. PubMed ID: 6693133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inherited deficiency of the third component of complement, C3, in guinea pigs.
    Burger R; Gordon J; Stevenson G; Ramadori G; Zanker B; Hadding U; Bitter-Suermann D
    Eur J Immunol; 1986 Jan; 16(1):7-11. PubMed ID: 3512275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3- and T-cell-dependent adjuvant activity of in vivo formed immune complexes.
    Van den Berg CW; Hazenberg MA; Hofhuis FM; Van Rooyen SM; Van Dijk H
    Immunology; 1991 Jul; 73(3):264-70. PubMed ID: 1879875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Components of human complement system. Testing and isolation of C3 and C5].
    Kosiak AV; Shukun SA; Poddubkova TN; Chikh VP; Surovtsev VI
    Biokhimiia; 1990 Feb; 55(2):276-84. PubMed ID: 2340315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.
    Alper CA; Colten HR; Gear JS; Rabson AR; Rosen FS
    J Clin Invest; 1976 Jan; 57(1):222-9. PubMed ID: 1107355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation in semisolid media: insolubilization of alternative pathway convertases in agar gels with C3 nephritic factor-containing sera.
    Arnaout MA; Davis AE; Rosen RS; Alper CA
    J Immunol; 1977 Oct; 119(4):1316-20. PubMed ID: 894039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary C3 hypocomplementemia in the rabbit.
    Komatsu M; Yamamoto K; Nakano Y; Nakazawa M; Ozawa A; Mikami H; Tomita M; Migita S
    Immunology; 1988 Jul; 64(3):363-8. PubMed ID: 3410489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.
    Rosenfeld SI; Kelly ME; Leddy JP
    J Clin Invest; 1976 Jun; 57(6):1626-34. PubMed ID: 932197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.
    Kitamura H; Matsumoto M; Nagaki K
    Immunology; 1984 Nov; 53(3):575-82. PubMed ID: 6237987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonspecific activation of complement factor 5 by isolated Dermacentor andersoni salivary antigens.
    Gordon JR; Allen JR
    J Parasitol; 1991 Apr; 77(2):296-301. PubMed ID: 2010863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identity of C3- and C5-receptors on lymphoid cells.
    Landen B; Dierich MP
    J Immunol; 1979 Mar; 122(3):1015-7. PubMed ID: 448068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A congenital deficiency of the C3 fraction of complement. A familial study].
    Sassi F; Bejaoui M; Ayed K
    Tunis Med; 2003 May; 81(5):354-8. PubMed ID: 12934459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.
    Ruseva MM; Hughes TR; Donev RM; Sivasankar B; Pickering MC; Wu X; Harris CL; Morgan BP
    Mol Immunol; 2009 Feb; 46(5):803-11. PubMed ID: 18947875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
    Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
    J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolysis of normal human erythrocytes by autologous serum complement.
    Kitamura H; Nagano A; Kitano E
    Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
    Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T
    Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.